Mieko Matsuyama

1.1k citations
10 papers · 203 indexed · h-index 6
Topics
Cell death mechanisms and regulation (4 papers)Epigenetics and DNA Methylation (3 papers)Immunotherapy and Immune Responses (2 papers)

In The Last Decade

Mieko Matsuyama

10 papers receiving 202 citations

Peers

Mieko Matsuyama
Comparison fields: 5 of 71
  • Molecular Biology 143
  • Cancer Research 31
  • Immunology 26
  • Epidemiology 25
  • Physiology 19
Replace Anwesh Kamireddy with:
Anwesh Kamireddy United States
Olaya Santiago‐Fernández United States
Aarti D. Rohira United States
Chenyue Shi Germany
Jenny Fung Ling Chau Singapore
Federica Morisi Italy
Qilin Gu China
Yichun He China
Unnur Thorsteindottir United Kingdom
Beiwu Lan China
Mieko Matsuyama relative to Anwesh Kamireddy United States Anwesh Kamireddy's profile →
Citations per field
00.5×1.6×
Anwesh Kamireddy · 1×
Citations per year

Countries citing papers authored by Mieko Matsuyama

Since Specialization
Citations

This map shows the geographic impact of Mieko Matsuyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mieko Matsuyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mieko Matsuyama more than expected).

Fields of papers citing papers by Mieko Matsuyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mieko Matsuyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mieko Matsuyama. The network helps show where Mieko Matsuyama may publish in the future.

Co-authorship network of co-authors of Mieko Matsuyama

This figure shows the co-authorship network connecting the top 25 collaborators of Mieko Matsuyama. A scholar is included among the top collaborators of Mieko Matsuyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mieko Matsuyama. Mieko Matsuyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 1
2 3
3 5
4 35
5 13
6 39
7 13
8 19
9 73
10 2

About Mieko Matsuyama

Mieko Matsuyama is a scholar working on Immunology, Ophthalmology and Molecular Biology, having authored 10 papers that have together received 203 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (4 papers), Epigenetics and DNA Methylation (3 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Aging (5 citations), Molecular Biology (143 citations) and Cancer Research (31 citations). Mieko Matsuyama has collaborated with scholars based in United States, Norway and Canada. Frequent co-authors include Shigemi Matsuyama, Terri H. Finkel, Clark Distelhorst, Minh Lam, Karen McColl, Sarah Swerdlow, Jason K. Molitoris, Steve Horvath, David N. Wald and Jochen Buechner. Their work appears in journals such as Journal of Biological Chemistry, Cell Death and Disease and Experimental Biology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026